Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Neurological Sciences
Published in: Neurological Sciences 1/2011

01-05-2011 | Migraine and Depression

Consultation-liaison psychiatry for patients with headaches

Authors: O. Gambini, V. Barbieri, B. Biagianti, S. Scarone

Published in: Neurological Sciences | Special Issue 1/2011

Login to get access

Abstract

Screening of headache patients for psychiatric disorders is needed, because of the well-known high rates of comorbidity with depression and anxiety. Screening for both depression and anxiety is highly advisable in order to identify subjects who need psychiatric consultation and therapy. Screening tools for depression and anxiety range from informal questions to self-report instruments to structured interviews and the choice is up to the clinician and the setting of the clinical evaluation. Data on psychiatric disorders and medication overuse are till now not consistent. The treatment of mood and anxiety disorders in headache patients needs to take into account the possible drug interactions with headache therapies. The collaboration between neurologists and consultation-liaison psychiatrists helps the identification of headache patients who need a psychiatric therapeutic program and follow-up.
Literature
1.
Lipchik GL, Penzien DB (2004) Psychiatric comorbidities in patients with headache. Semin Pain Med 2:93–105CrossRef
2.
Kalayadjian A, Merikangas K (2008) Physical and mental cmomorbidity of headache in a nationally representative sample of US adults. Psychosom Med 70:773–780CrossRef
3.
Beghi E, Bussone G, D’Amico D et al (2010) Headache, anxiety and depressive disorder: the HADA study. J Headache Pain 11:141–150PubMedCrossRef
4.
Maizels M, Smitherman TA, Penzien DB (2006) A review of screening tools for psychiatric comorbidity in headache patients. Headache 46(s3):s98–s109PubMedCrossRef
5.
Borkum JM (2010) Chronic headaches and the neurobiology of somatization. Curr Pain Headache Rep 14:55–61PubMedCrossRef
6.
D'Amico D, Libro G, Prudenzano P et al (2000) Stress and chronic headache. J Headache Chronic Pain 1:S549–S552
7.
Lake AE III, Rains JC, Penzien DB et al (2005) Headache and psychiatric comorbidity: historical context, clinical implications and research relevance. Headache 45:493–506PubMedCrossRef
8.
Pompili M, Di Cosimo D, Innamorati M, Lester D et al (2009) Psychiatric comorbidity in patients with chronic daily headache and migraine: a selective overview including personality traits and suicide risk. J Headache Pain 10:283–290PubMedCrossRef
9.
Kalaydjian A, Eaton W, Zandi P (2007) Migraine headaches are not associated with a unique depressive symptom profile: results from Baltimore Epidemiologic Cathment Area Study. J Psychosom Res 63:123–129PubMedCrossRef
10.
Smitherman TA, Maizels M, Penzien DB (2008) Headache chronification: screening and behavioural management of comorbid depressive and anxiety disorders. Headache 48:45–50
11.
Aarre TF, Dahl AA (2008) Pharmacotherapy for bipolar depression: a review of the evidence. Curr Psychiatr Rev 4:145–156CrossRef
12.
Holroyd KA, Labus JS, Carlson B (2009) Moderation and mediation in the psychological and drug treatment of chronic tension-type headache: the role of disorder severity and psychiatric comorbidity. Pain 143:213–222PubMedCrossRef
13.
Griffith JL, Razavi M (2006) Pharmachological management of mood and anxiety disorders in headache patients. Headache 46(s):s133–141
14.
Dalton SO, Sørensen HT, Johansen C (2006) SSRIs and upper gastrointestinal bleeding. What is known and how should it influence prescribing? CNS Drugs 20(2):143–151PubMedCrossRef
15.
Wenzel RG, Tepper S, Korab WE (2008) Serotonine syndrome risk when combining SSRI/SNRI drugs and triptans:is the FDA’s alert warranted? Ann Pharmacother 42:1692–1696PubMedCrossRef
16.
Evans RW, Stewart JT, Shapiro RE et al (2010) The FDA alert on serotonine syndrome with use of triptans combined with selective serotonin inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American headache society position paper. Headache 50:1089–1099
Metadata
Title
Consultation-liaison psychiatry for patients with headaches
Authors
O. Gambini
V. Barbieri
B. Biagianti
S. Scarone
Publication date
01-05-2011
Publisher
Springer Milan
Published in
Neurological Sciences / Issue Special Issue 1/2011
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-011-0533-4

Other articles of this Special Issue 1/2011

Neurological Sciences 1/2011 Go to the issue

Treatment

Nose and headache: what have we learned?

Symposium - Chronic Pain and Headache: New Legislation

Italian Law “Measures to guarantee the access to palliative and pain treatments”: rebound on headaches’ management

Migraine and Depression

Migraine and depression: common pathogenetic and therapeutic ground?

Brief Communication

Undertreatment in patients with primary headaches attending headache centres

Migraine Pathophysiology

Brain white matter lesions in migraine: what’s the meaning?

Invited Lecture

Pain emotion and homeostasis